1. Home
  2. ENSC vs REED Comparison

ENSC vs REED Comparison

Compare ENSC & REED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

N/A

Current Price

$0.39

Market Cap

8.2M

Sector

Health Care

ML Signal

N/A

Logo Reed's Inc.

REED

Reed's Inc.

N/A

Current Price

$0.71

Market Cap

8.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ENSC
REED
Founded
2003
1987
Country
United States
United States
Employees
10
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
8.8M
IPO Year
2017
2009

Fundamental Metrics

Financial Performance
Metric
ENSC
REED
Price
$0.39
$0.71
Analyst Decision
Analyst Count
0
0
Target Price
★ $5.13
N/A
AVG Volume (30 Days)
535.6K
★ 2.6M
Earning Date
11-13-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 65.24
N/A
EPS
★ N/A
N/A
Revenue
$5,066,650.00
★ $34,065,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$27.29
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.23
$0.33
52 Week High
$2.17
$5.97

Technical Indicators

Market Signals
Indicator
ENSC
REED
Relative Strength Index (RSI) 36.37 56.68
Support Level $0.39 $0.72
Resistance Level $0.44 $1.04
Average True Range (ATR) 0.05 0.17
MACD -0.01 0.04
Stochastic Oscillator 2.44 54.32

Price Performance

Historical Comparison
ENSC
REED

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About REED Reed's Inc.

Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands. The company's portfolio of handcrafted, all-natural beverages is sold in outlets nationwide, including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores, and on-premise locations, including bars and restaurants. The company operates in a single reportable segment, which consists of manufacturing carbonated beverages under Reed's and Virgil's brand names.

Share on Social Networks: